Literature DB >> 12915568

Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.

Florent C Bender1, J Charles Whitbeck, Manuel Ponce de Leon, Huan Lou, Roselyn J Eisenberg, Gary H Cohen.   

Abstract

Herpes simplex virus (HSV) entry requires the interaction of glycoprotein D (gD) with a cellular receptor such as herpesvirus entry mediator (HVEM or HveA) or nectin-1 (HveC). However, the fusion mechanism is still not understood. Since cholesterol-enriched cell membrane lipid rafts are involved in the entry of other enveloped viruses such as human immunodeficiency virus and Ebola virus, we tested whether HSV entry proceeds similarly. Vero cells and cells expressing either HVEM or nectin-1 were treated with cholesterol-sequestering drugs such as methyl-beta-cyclodextrin or nystatin and then exposed to virus. In all cases, virus entry was inhibited in a dose-dependent manner, and the inhibitory effect was fully reversible by replenishment of cholesterol. To examine the association of HVEM and nectin-1 with lipid rafts, we analyzed whether they partitioned into nonionic detergent-insoluble glycolipid-enriched membranes (DIG). There was no constitutive association of either receptor with DIG. Binding of soluble gD or virus to cells did not result in association of nectin-1 with the raft-containing fractions. However, during infection, a fraction of gB but not gC, gD, or gH associated with DIG. Similarly, when cells were incubated with truncated soluble glycoproteins, soluble gB but not gC was found associated with DIG. Together, these data favor a model in which HSV uses gB to rapidly mobilize lipid rafts that may serve as a platform for entry and cell signaling. It also suggests that gB may interact with a cellular molecule associated with lipid rafts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915568      PMCID: PMC187402          DOI: 10.1128/jvi.77.17.9542-9552.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

Review 1.  Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.

Authors:  F G van der Goot; T Harder
Journal:  Semin Immunol       Date:  2001-04       Impact factor: 11.130

2.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

Review 3.  Floating the raft hypothesis: lipid rafts play a role in immune cell activation.

Authors:  A Cherukuri; M Dykstra; S K Pierce
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

4.  Sphingomyelin-enriched microdomains at the Golgi complex.

Authors:  I Gkantiragas; B Brügger; E Stüven; D Kaloyanova; X Y Li; K Löhr; F Lottspeich; F T Wieland; J B Helms
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

5.  CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts.

Authors:  M A Doucey; D F Legler; N Boucheron; J C Cerottini; C Bron; I F Luescher
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

Review 6.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

7.  Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.

Authors:  M Higuchi; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

8.  Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains.

Authors:  O W Lindwasser; M D Resh
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.

Authors:  C Amici; G Belardo; A Rossi; M G Santoro
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

10.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

View more
  105 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

2.  Envelope lipid-packing as a critical factor for the biological activity and stability of alphavirus particles isolated from mammalian and mosquito cells.

Authors:  Ivanildo P Sousa; Carlos A M Carvalho; Davis F Ferreira; Gilberto Weissmüller; Gustavo M Rocha; Jerson L Silva; Andre M O Gomes
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

4.  Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins.

Authors:  Fushan Wang; Waixing Tang; Helen M McGraw; Jean Bennett; Lynn W Enquist; Harvey M Friedman
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Huan Lou; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.

Authors:  Richard S B Milne; Anthony V Nicola; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions.

Authors:  Florent C Bender; Minu Samanta; Ekaterina E Heldwein; Manuel Ponce de Leon; Elina Bilman; Huan Lou; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

8.  Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes.

Authors:  Tatiana Gianni; Gabriella Campadelli-Fiume; Laura Menotti
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.

Authors:  Marcio O Lasaro; Nia Tatsis; Scott E Hensley; J Charles Whitbeck; Shih-Wen Lin; John J Rux; E John Wherry; Gary H Cohen; Roselyn J Eisenberg; Hildegund C Ertl
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

10.  Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol.

Authors:  Kathleen Boesze-Battaglia; Angela Brown; Lisa Walker; Dave Besack; Ali Zekavat; Steve Wrenn; Claude Krummenacher; Bruce J Shenker
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.